The following section summarizes insights on undefined's Shares Outstanding Adjustment Factor:
Aequus Pharmaceuticals's latest twelve months net income to common excl extra items is -2.676 million
Aequus Pharmaceuticals's net income to common excl extra items for fiscal years ending December 2019 to 2023 averaged -2.427 million.
Aequus Pharmaceuticals's operated at median net income to common excl extra items of -2.965 million from fiscal years ending December 2019 to 2023.
Looking back at the last 5 years, Aequus Pharmaceuticals's net income to common excl extra items peaked in December 2020 at -1.045 million.
Aequus Pharmaceuticals's net income to common excl extra items hit its 5-year low in December 2022 of -3.21 million.
Aequus Pharmaceuticals's net income to common excl extra items decreased in 2019 (-3.106 million, +10.8%), 2021 (-1.81 million, +73.1%) and 2022 (-3.21 million, +77.4%) and increased in 2020 (-1.045 million, -66.3%) and 2023 (-2.965 million, -7.6%).
Press space bar to start a drag.
When dragging you can use the arrow keys to move the item around and escape to cancel.
Some screen readers may require you to be in focus mode or to use your pass through key